Contact us:

Customer Service
1800 008 275
customer.service.au@seqirus.com

Product or Medical Information
1800 642 865
aunz.medicalinformation@seqirus.com

To report an adverse event to a CSL Seqirus product click here

Address:

655 Elizabeth St,
Melbourne VIC 3000

Your own healthcare professional is the best source of information regarding your health.

For Information regarding Nervoderm or to report an adverse event please call 1800 642 865.

Always read the label. Follow the directions for use. If symptoms persist, talk to your healthcare professional.

1. Rowbotham MC et al. Pain 1996;65(1):39–44. 2. Katz NP et al. Pain Med 2002;3(4):324 –32. (Funded by Endo Pharmaceuticals) 3. Sabatowski R et al. Curr Med Res Opin 2012; 28(8):1337–46. Results achieved in a 3-year extension trial assessing pain relief in patients with PHN using Nervoderm (up to 3 patches). Funded by Grünenthal GmbH.4. Nervoderm® Approved Consumer Medicine Information July 2016. 5. Rehm S et al Curr Med Res & Opin 2010;26(7):1607-1619
Nervoderm© is a registered trademark of Seqirus™ UK Ltd or its affiliates. Seqirus™ (Australia) Pty Ltd ABN 66 120 398 067, 655 Elizabeth St, Melbourne VIC 3000. Medical information: 1800 642 865. Date of preparation: December 23. AU-NVD-23-0013. SEQ-002510-00.

©2021 Nervoderm. All rights reserved.
Privacy Policy    Cookie Policy